Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector 
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs 
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal 
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth 
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition 
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth 
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio 
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push 
 Announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, Feb. 17, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in Connecticut on behalf of certain purchasers of shares of CIGNA Corporation (NYSE:CI) over alleged Securities Laws Violations by CIGNA Corporation (NYSE:CI).
Investors who purchased shares of CIGNA Corporation (NYSE:CI) have certain options and for certain investors there are short and strict deadlines running. Deadline: April 6, 2016. NYSE:CI investors should contact the Shareholders Foundation at [email protected] or call +1 (858) 779-1554.
The plaintiff claims that Defendants allegedly made certain false and/or misleading statements and/or failed to disclose that Cigna’s appeals and grievances procedures were not in compliance with federal standards, that Cigna’s noncompliance with federal standards posed a serious threat to the health and safety of Medicare beneficiaries, and that as a result of the foregoing, Cigna’s public statements were materially false and misleading at all relevant times.
On January 22, 2016, CIGNA Corporation announced that on January 21, 2016 it was notified by the Centers for Medicare & Medicaid Services ("CMS") of its intent to impose intermediate sanctions suspending the enrollment of and marketing to new customers of all Cigna Medicare Advantage and Standalone Prescription Drug Plan Contracts.
Those who purchased CIGNA Corporation (NYSE:CI) shares should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108
